Merck & Co. analyst consensus shapes Tuesday view, shares near recent NYSE range
23.06.2026 - 15:01:21 | ad-hoc-news.de
By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-23, 14:59.
Merck & Co. (US58933Y1055) sits on Tuesday in a clearly defined analyst consensus while its shares trade steadily on the NYSE around the mid-point of their recent range, according to data from MarketBeat and TrendSpider.
What analysts are signaling
Data aggregators such as MarketBeat currently show Merck & Co. covered by a broad set of houses, with the majority of ratings in the Buy or Outperform camp and a smaller group on Hold, resulting in a constructive consensus on the large cap pharma name.
The average 12-month price target compiled on MarketBeat stands above the latest NYSE closing price of around 115 US dollars, indicating that analysts as a group still see upside potential from current levels based on their earnings and pipeline models.
Consensus picture on Tuesday
On the price side, TrendSpider data point to Merck & Co. shares most recently closing at about 115.48 US dollars on the NYSE, a level that leaves the stock roughly in the middle of the trading corridor observed in recent weeks and only modestly below the June highs.
Finanzen100, which tracks the German-traded Merck & Co. line under the symbol 6MK, reports a last price near 101.86 euros, giving European investors a parallel view on the US pharmaceutical group and underscoring the international reach of the stock.
All news and analysis on the Merck & Co. shares
Further coverage, price data and background reports on Merck & Co. are available in the dedicated topic section and via the company's investor relations pages.
The products behind the earnings
Merck & Co. generates most of its revenue from prescription medicines, with cancer immunotherapy KEYTRUDA, vaccines such as GARDASIL for HPV, and cardiovascular and infectious disease treatments forming core pillars of the portfolio alongside animal health products.
Where the shares trade today
The Merck & Co. shares (US58933Y1055) most recently traded on the NYSE at around 115.48 US dollars as of the closing auction on 2026-06-22, per TrendSpider data.
Key data on the Merck & Co. shares
- Company: Merck & Co., Inc.
- ISIN: US58933Y1055
- WKN: A0YD8Q
- Ticker: MRK
- Trading venue: NYSE
- Price (as of 2026-06-22, 21:59): 115.48 US dollars
- Market cap: approximately 292 billion US dollars (as of 2026-06-22)
- Sector / industry: Pharmaceuticals, Biotechnology & Life Sciences
- Index membership: Dow Jones Industrial Average, S&P 500
- Next earnings date: not officially scheduled
Disclaimer: This text is for informational purposes only and does not constitute investment advice, tax advice or a solicitation to buy or sell securities. All data are based on sources believed to be reliable but cannot be guaranteed. Investors should conduct their own research and consider their individual financial situation.
